Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284564
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-02-21
Brief Title:
A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma BOOST-RCC
Sponsor:
Organization:
MD Anderson Cancer Center